Vascular Neurology Considerations for Anti-Amyloid Immunotherapy
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Authors Mark Fisher, MD and Steve Greenberg, MD announce the publication of the science advisory in the journal STROKE and discuss predictors of ARIA, the use of antithrombotic and thrombolytic medications in patients receiving anti-amyloid therapy, and suggested treatment approaches.
Recommended Videos
Overview and Risk Factors of Cerebral Venous Thrombosis
Diagnosis and Management of Cerebral Venous Thrombosis Key Takeaways
Management of Cerebral Venous Thrombosis
Disparities in Healthcare: Exploring Supraventricular Tachycardia in Pregn...
Approach to Patient Decision Making for Cardiogenic Shock in Older Adults
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.